Investigation of molecular markers in the diagnosis of refractory coeliac disease in a large patient cohort

Journal of Clinical Pathology

Volumn 61, Issue 11, 2008, Pages 1200-1202

  O'Shea, U ^a   Abuzakouk, M ^a   O'Morain, C ^b   O'Donoghue, D ^c   Sheahan, K ^c   Watson, P ^d   O'Briain, S ^a   Alexander, D ^e   Catherwood, M ^e   Jackson, J ^a   Kelly, J ^f   Feighery, Conleth ^a  

^a ST JAMES S HOSPITAL   (Ireland)

^b ADELAIDE AND MEATH HOSPITAL   (Ireland)

^c ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^d ROYAL VICTORIA HOSPITAL   (United Kingdom)

^e BELFAST CITY HOSPITAL   (United Kingdom)

^f DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD8 ANTIGEN; GLUTEN; MOLECULAR MARKER; MONOCLONAL ANTIBODY; T LYMPHOCYTE RECEPTOR; BIOLOGICAL MARKER; CD3E PROTEIN, HUMAN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CELIAC DISEASE; CLINICAL ARTICLE; CLONAL VARIATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; GLUTEN FREE DIET; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE BIOPSY; IRELAND; LABORATORY DIAGNOSIS; LYMPHOCYTE SUBPOPULATION; MALE; PATIENT COMPLIANCE; PATIENT INFORMATION; PHENOTYPE; PRIORITY JOURNAL; QUESTIONNAIRE; REFRACTORY COELIAC DISEASE; SENSITIVITY AND SPECIFICITY; STAINING; T LYMPHOCYTE; CELL CLONE; COHORT ANALYSIS; DIET THERAPY; ENZYME IMMUNOASSAY; IMMUNOLOGY; INTESTINE MUCOSA; METABOLISM; MIDDLE AGED; MUCOSAL IMMUNITY; SMALL INTESTINE; T LYMPHOCYTE SUBPOPULATION; TREATMENT FAILURE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD3; ANTIGENS, CD8; BIOLOGICAL MARKERS; CELIAC DISEASE; CLONE CELLS; COHORT STUDIES; FEMALE; HUMANS; IMMUNITY, MUCOSAL; IMMUNOENZYME TECHNIQUES; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; MIDDLE AGED; T-LYMPHOCYTE SUBSETS; TREATMENT FAILURE;

EID: 56049090563     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2008.058404     Document Type: Article

References (22)

1. Green PH, Cellier C. Celiac disease. Review. N Engl J Med 2007;357:1731-43.
2. Feighery C. Fortnightly review: coeliac disease. BMJ 1999;319:236-9.
3. O'Mahony S, Howdle PD, Lowsowsky MS. Management of patients with non-responsive coeliac disease. Aliment Phermacol Ther 1996;10:671-80.
4. Goerres M, Meijer J, Wahab P, et al. Azathioprine and prednisone combination therapy in refractory coeliac disease. Aliment Pharmacol Ther 2003;18:487-94.
5. Daum S. Cellier C, Mulder CJ. Refractory coeliac disease. Best Pract Res Clin Gastroenterol 2005;19:413-24.
6. Cellier C, Patey N, Mauvieux L. et al. Abnormal intestinal intraepithelial lymphocytes in refractory sprue. Gastroenterology 1998;114:471-81.
7. Cellier C, Delabesse E, Helmer C. et al. Refractory sprue, coeliac disease and enteropathy-associated T-cell lymphoma. Lancet 2000;356:203-8.
8. Bagdi E, Diss T, Munson P, et al. Mucosal intra-epithelial lymphocytes in enteropathy-associated T-cell lymphoma, ulcerative jejunitis, and refractory celiac disease constitute a neoplastic population. Blood 1999;94:260-4.
9. Daum S, Weiss D, Hummel M, et al. Intestinal Lymphoma Study Group. Frequency of clonal intraepithelial T lymphocyte proliferations in enteropathy-type intestinal T cell lymphoma, coeliac disease, and refractory sprue. Gut 2001;49:804-12.
10. O'Farrelly C, Feighery C, O'Briain DS, et al. Humoral response to wheat protein in patients with coeliac disease and enteropathy associated T cell lymphoma. Br Med J (Clin Res Ed) 1986;293:908- 10.
11. Ferreira M, Lloyd Davies S, Butler M, et al. Endomysial antibody: is it the best screening test for coeliac disease? Gut 1992;33:1633-7.
12. Dieterich W, Laag E, Schopper H, et al. Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology 1998;115:1584-94.
13. Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 1999;11:1185-94.
14. Mohamed BM, Feighery C, Kelly J, et al. Increased protein expression of matrix metalloproteinases -1, -3, and -9 and TIMP-1 in patients with gluten-sensitive enteropathy. Dig Dis Sci 2006;51:1862-8.
15. Assaf C, Hummel M, Dippel E, et al. High detection rate of T-cell receptor beta chain rearrangements in T-cell lymphoproliferations by family specific polymerase chain reaction in combination with the GeneScan technique and DNA sequencing. Blood 2000;96:640-6.
16. van Dongen JJ, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003;12:2257-317.
17. Al-Toma A, Verbeek WH, Hadithi M, et al. Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience. Gut 2007;56:1373-8.
18. Kelly J, O'Farrelly C, O'Mahony C, et al. Immunoperoxidase demonstration of the cellular composition of the normal and coeliac small bowel. Clin Exp Immunol 1987;68:177-88.
19. Verbeek WH, Goerres MS, von Blomberg BM, et al. Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in refractory celiac disease. Clin Immunol 2008;126:48-56.
20. Ciacci C, Cirillo M, Cavallaro R, et al. Long-term follow-up of celiac adults on gluten-free diet: prevalence and correlates of intestinal damage. Digestion 2002;66:178-85.
21. Grefte JM, Bouman JG, Grand J, et al. Slow and incomplete histological and functional recovery in adult gluten sensitive enteropathy. J Clin Pathol 1988;41:886-91.
22. Dickey W, Hughes D, McMillan S. Disappearance of endomysial antibodies in treated celiac disease does not indicate histological recovery. Am J Gastroenterol 2000;95:712-4.